News & Events

Starting Antiretroviral Treatment Early Improves Outcomes for HIV-Infected Individuals NIH-Funded Trial Results Likely Will Impact Global Treatment Guidelines

Tulane’s Louisiana Community AIDS Research Program (LaCARP) participated in the international START study, comparing early versus delayed initiation of HAART. Dr. David Mushatt is the Principal Investigator for the Tulane site. The Data Safety and Monitoring Board recently analyzed the data and announced that early treatment resulted in a greater than 50% reduction in the combined endpoint of serious AIDS events (such as AIDS-related cancer), serious non-AIDS events (major cardiovascular, renal and liver disease and cancer), and death.

See NIH Press Release:

1430 Tulane Ave, New Orleans, LA 70112 504-988-3606